Stock Price
14.56
Daily Change
-0.22 -1.49%
Monthly
-1.09%
Yearly
37.62%
Q2 Forecast
14.12

Amarin reported 91.05 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amarin 91.05 88.3 Jun/2023
AstraZeneca 29.59 2.3 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 14.87 3.72 Mar/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novartis 20.17 2.32 Mar/2026